A Critical Regulatory Role for Macrophage Migration Inhibitory Factor in Hyperoxia-Induced Injury in the Developing Murine Lung

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Sun, Huanxing ^a   Choo Wing, Rayman ^a   Sureshbabu, Angara ^a   Fan, Juan ^b   Leng, Lin ^b   Yu, Shuang ^b   Jiang, Dianhua ^c   Noble, Paul ^c   Homer, Robert J ^a   Bucala, Richard ^b   Bhandari, Vineet ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA; ANGIOPOIETIN; INTERLEUKIN 6; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR;

AMBIENT AIR; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO PATTERN FORMATION; GENOTYPE; HYPOXIA; LUNG DEVELOPMENT; LUNG INJURY; MORPHOMETRICS; MORTALITY; MOUSE; NEWBORN; NONHUMAN; NOTOCHORD; PATHOGENESIS; PERINATAL PERIOD; PROTEIN EXPRESSION; RNA ANALYSIS; ANIMAL; CELL COUNT; COMPLICATION; DEFICIENCY; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HYPEROXIA; LUNG; LUNG LAVAGE; METABOLISM; PATHOLOGY; PHENOTYPE; TRANSGENIC MOUSE;

MURINAE; MUS MUSCULUS;

ANGIOPOIETINS; ANIMALS; BRONCHOALVEOLAR LAVAGE; CELL COUNT; GENE EXPRESSION REGULATION; GENE KNOCKOUT TECHNIQUES; HYPEROXIA; INTERLEUKIN-6; LUNG; LUNG INJURY; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MICE; MICE, TRANSGENIC; PHENOTYPE; RECEPTOR, TIE-2; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84876719674     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060560     Document Type: Article

References (45)

1. Bhandari V, Elias JA, (2006) Cytokines in tolerance to hyperoxia-induced injury in the developing and adult lung. Free Radic Biol Med 41: 4-18.
2. Bhandari V, (2008) Molecular mechanisms of hyperoxia-induced acute lung injury. Front Biosci 13: 6653-6661.
3. Bhandari V, (2002) Developmental differences in the role of interleukins in hyperoxic lung injury in animal models. Front Biosci 7: d1624-1633.
4. Kevill KA, Bhandari V, Kettunen M, Leng L, Fan J, et al. (2008) A role for macrophage migration inhibitory factor in the neonatal respiratory distress syndrome. J Immunol 180: 601-608.
5. Bondza PK, Metz CN, Akoum A, (2008) Postgestational effects of macrophage migration inhibitory factor on embryonic implantation in mice. Fertil Steril 90: 1433-1443.
6. Ren Y, Law S, Huang X, Lee PY, Bacher M, et al. (2005) Macrophage migration inhibitory factor stimulates angiogenic factor expression and correlates with differentiation and lymph node status in patients with esophageal squamous cell carcinoma. Ann Surg 242: 55-63.
7. Ren Y, Chan HM, Li Z, Lin C, Nicholls J, et al. (2004) Upregulation of macrophage migration inhibitory factor contributes to induced N-Myc expression by the activation of ERK signaling pathway and increased expression of interleukin-8 and VEGF in neuroblastoma. Oncogene 23: 4146-4154.
8. White ES, Flaherty KR, Carskadon S, Brant A, Iannettoni MD, et al. (2003) Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosis. Clin Cancer Res 9: 853-860.
9. Veillat V, Carli C, Metz CN, Al-Abed Y, Naccache PH, et al. (2010) Macrophage migration inhibitory factor elicits an angiogenic phenotype in human ectopic endometrial cells and triggers the production of major angiogenic factors via CD44, CD74, and MAPK signaling pathways. J Clin Endocrinol Metab 95: E403-412.
10. Xu X, Wang B, Ye C, Yao C, Lin Y, et al. (2008) Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer. Cancer Lett 261: 147-157.
11. Bondza PK, Metz CN, Akoum A, (2008) Macrophage migration inhibitory factor up-regulates alpha(v)beta(3) integrin and vascular endothelial growth factor expression in endometrial adenocarcinoma cell line Ishikawa. J Reprod Immunol 77: 142-151.
12. Ren Y, Tsui HT, Poon RT, Ng IO, Li Z, et al. (2003) Macrophage migration inhibitory factor: roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinoma. Int J Cancer 107: 22-29.
13. Kim HR, Park MK, Cho ML, Yoon CH, Lee SH, et al. (2007) Macrophage migration inhibitory factor upregulates angiogenic factors and correlates with clinical measures in rheumatoid arthritis. J Rheumatol 34: 927-936.
14. Donnelly SC, Haslett C, Reid PT, Grant IS, Wallace WA, et al. (1997) Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med 3: 320-323.
15. DiCosmo BF, Geba GP, Picarella D, Elias JA, Rankin JA, et al. (1994) Airway epithelial cell expression of interleukin-6 in transgenic mice. Uncoupling of airway inflammation and bronchial hyperreactivity. J Clin Invest 94: 2028-2035.
16. Mitchell R, Bacher M, Bernhagen J, Pushkarskaya T, Seldin MF, et al. (1995) Cloning and characterization of the gene for mouse macrophage migration inhibitory factor (MIF). J Immunol 154: 3863-3870.
17. Perl AK, Wert SE, Loudy DE, Shan Z, Blair PA, et al. (2005) Conditional recombination reveals distinct subsets of epithelial cells in trachea, bronchi, and alveoli. Am J Respir Cell Mol Biol 33: 455-462.
18. Lee CG, Link H, Baluk P, Homer RJ, Chapoval S, et al. (2004) Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat Med 10: 1095-1103.
19. Bhandari V, Choo-Wing R, Chapoval SP, Lee CG, Tang C, et al. (2006) Essential role of nitric oxide in VEGF-induced, asthma-like angiogenic, inflammatory, mucus, and physiologic responses in the lung. Proc Natl Acad Sci U S A 103: 11021-11026.
20. Bhandari V, Choo-Wing R, Lee CG, Yusuf K, Nedrelow JH, et al. (2008) Developmental regulation of NO-mediated VEGF-induced effects in the lung. Am J Respir Cell Mol Biol 39: 420-430.
21. Choo-Wing R, Nedrelow JH, Homer RJ, Elias JA, Bhandari V, (2007) Developmental differences in the responses of IL-6 and IL-13 transgenic mice exposed to hyperoxia. Am J Physiol Lung Cell Mol Physiol 293: L142-150.
22. Harijith A, Choo-Wing R, Cataltepe S, Yasumatsu R, Aghai ZH, et al. (2011) A role for matrix metalloproteinase 9 in IFNgamma-mediated injury in developing lungs: relevance to bronchopulmonary dysplasia. Am J Respir Cell Mol Biol 44: 621-630.
23. Doube M, Klosowski MM, Arganda-Carreras I, Cordelieres FP, Dougherty RP, et al. (2010) BoneJ: Free and extensible bone image analysis in ImageJ. Bone 47: 1076-1079.
24. Bhandari V, Choo-Wing R, Homer RJ, Elias JA, (2007) Increased Hyperoxia-Induced Mortality and Acute Lung Injury in IL-13 Null Mice. J Immunol 178: 4993-5000.
25. Bhandari V, Choo-Wing R, Lee CG, Zhu Z, Nedrelow JH, et al. (2006) Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death. Nat Med 12: 1286-1293.
26. de Visser YP, Walther FJ, Laghmani el H, Steendijk P, Middeldorp M, et al. (2012) Phosphodiesterase 4 inhibition attenuates persistent heart and lung injury by neonatal hyperoxia in rats. Am J Physiol Lung Cell Mol Physiol 302: L56-67.
27. Thebaud B, Abman SH, (2007) Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease. Am J Respir Crit Care Med 175: 978-985.
28. Munaut C, Boniver J, Foidart JM, Deprez M, (2002) Macrophage migration inhibitory factor (MIF) expression in human glioblastomas correlates with vascular endothelial growth factor (VEGF) expression. Neuropathol Appl Neurobiol 28: 452-460.
29. Dani C, Corsini I, Burchielli S, Cangiamila V, Romagnoli R, et al. (2011) Natural surfactant combined with beclomethasone decreases lung inflammation in the preterm lamb. Respiration 82: 369-376.
30. Tang F, Yue S, Luo Z, Feng D, Wang M, et al. (2005) Role of N-methyl-D-aspartate receptor in hyperoxia-induced lung injury. Pediatr Pulmonol 40: 437-444.
31. You K, Xu X, Fu J, Xu S, Yue X, et al. (2012) Hyperoxia disrupts pulmonary epithelial barrier in newborn rats via the deterioration of occludin and ZO-1. Respir Res 13: 36.
32. James ML, Ross AC, Bulger A, Philips JB 3rd, Ambalavanan N, (2010) Vitamin A and retinoic acid act synergistically to increase lung retinyl esters during normoxia and reduce hyperoxic lung injury in newborn mice. Pediatr Res 67: 591-597.
33. White CW, Greene KE, Allen CB, Shannon JM, (2001) Elevated expression of surfactant proteins in newborn rats during adaptation to hyperoxia. Am J Respir Cell Mol Biol 25: 51-59.
34. Bhandari V, Choo-Wing R, Harijith A, Sun H, Syed MA, et al. (2012) Increased hyperoxia-induced lung injury in nitric oxide synthase 2 null mice is mediated via angiopoietin 2. Am J Respir Cell Mol Biol 46: 668-676.
35. Aghai ZH, Faqiri S, Saslow JG, Nakhla T, Farhath S, et al. (2008) Angiopoietin 2 concentrations in infants developing bronchopulmonary dysplasia: attenuation by dexamethasone. J Perinatol 28: 149-155.
36. Saharinen P, Eklund L, Miettinen J, Wirkkala R, Anisimov A, et al. (2008) Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts. Nat Cell Biol 10: 527-537.
37. Hato T, Kimura Y, Morisada T, Koh GY, Miyata K, et al. (2009) Angiopoietins contribute to lung development by regulating pulmonary vascular network formation. Biochem Biophys Res Commun 381: 218-223.
38. Thebaud B, Ladha F, Michelakis ED, Sawicka M, Thurston G, et al. (2005) Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization. Circulation 112: 2477-2486.
39. Cohen JC, Lundblad LK, Bates JH, Levitzky M, Larson JE, (2004) The "Goldilocks effect" in cystic fibrosis: identification of a lung phenotype in the cftr knockout and heterozygous mouse. BMC Genet 5: 21.
40. Frenz DA, Liu W, Cvekl A, Xie Q, Wassef L, et al. Retinoid signaling in inner ear development: A "Goldilocks" phenomenon. Am J Med Genet A 152A: 2947-2961.
41. Compernolle V, Brusselmans K, Acker T, Hoet P, Tjwa M, et al. (2002) Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med 8: 702-710.
42. Yang G, Abate A, George AG, Weng YH, Dennery PA, (2004) Maturational differences in lung NF-kappaB activation and their role in tolerance to hyperoxia. J Clin Invest 114: 669-678.
43. Yang G, Madan A, Dennery PA, (2000) Maturational differences in hyperoxic AP-1 activation in rat lung. Am J Physiol Lung Cell Mol Physiol 278: L393-398.
44. Rogers LK, Tipple TE, Nelin LD, Welty SE, (2009) Differential responses in the lungs of newborn mouse pups exposed to 85% or >95% oxygen. Pediatr Res 65: 33-38.
45. Jorgensen WL, Gandavadi S, Du X, Hare AA, Trofimov A, et al. (2010) Receptor agonists of macrophage migration inhibitory factor. Bioorg Med Chem Lett 20: 7033-7036.